🔬 Urea and Electrolytes

Urea and Electrolytes (U&Es) are a standard blood panel used to assess renal function and fluid-electrolyte balance. The test measures sodium, potassium, urea, and creatinine, and providing a calculated eGFR. It is critical for diagnosing Acute Kidney Injury (AKI), monitoring Chronic Kidney Disease (CKD), and identifying life-threatening electrolyte imbalances. It is one of the most frequently ordered tests in zowel acute and primary care settings.

Indicated for any patient with acute illness, suspected dehydration, or kidney disease. It is used to monitor patients with chronic conditions like heart failure and hypertension, or those taking nephrotoxic medications. U&Es are essential in the workup of hypertension (to look for secondary causes or end-organ damage) and for pre-operative assessment. They are also measured in metabolic emergencies like Diabetic Ketoacidosis (DKA) or when investigating confusion and cardiac arrhythmias.

Blood is collected into a serum separator tube (SST, yellow top) or a lithium heparin tube (orange top). The lab uses ion-selective electrodes to measure sodium and potassium, while urea and creatinine are measured using enzymatic or colorimetric assays (e.g., the Jaffe reaction). The eGFR is then calculated using the CKD-EPI formula, incorporating age and sex. Prompt transport to the lab is necessary to avoid haemolysis, which releases intracellular potassium into the serum.

A normal U&E profile shows electrolytes and markers of renal function within laboratory ranges. Standard ranges: Sodium 135-145 mmol/L; Potassium 3.5-5.0 mmol/L; Urea 2.5-7.8 mmol/L; Creatinine 60-120 micromol/L (dependent on muscle mass). The eGFR should ideally be >90 mL/min/1.73m², although >60 is often considered normal in the absence of other kidney damage markers. Interpretation must account for the patient's age and sex.

Interpretation requires correlation with the patient's previous baseline. A 'normal' creatinine in a frail elderly patient with low muscle mass may actually represent significant renal impairment. The eGFR is only valid in steady-state conditions and is not reliable in AKI. When assessing hyponatremia, urinary sodium and osmolality are often required to determine the etiology (e.g., SIADH vs. diuretics). A 'clotted' or 'haemolysed' sample can falsely elevate potassium levels (pseudohyperkalaemia), necessitating a repeat.

Hyponatremia is common and requires assessment of fluid status (hypovolaemic, euvolaemic, or hypervolaemic). Hypernatremia often reflects dehydration. Hyperkalaemia is a medical emergency due to myocardial instability risks, whereas hypokalaemia can lead to ileus and arrhythmias. A raised urea out of proportion to creatinine may suggest upper GI bleeding (due to protein breakdown) or dehydration. Significant rises in creatinine relative to baseline indicate Acute Kidney Injury (AKI), graded by the KDIGO criteria. Low urea is less common but can occur in severe liver disease or malnutrition.

U&Es are vital for monitoring patients on diuretics, ACE inhibitors, or NSAIDs, which can impair renal function or alter electrolytes. They are essential in the management of cardiovascular disease, diabetes, and acute illnesses where fluid shifts occur. Clinicians use these results to calculate the Estimated Glomerular Filtration Rate (eGFR), which guides drug dosing and the management of Chronic Kidney Disease (CKD). Electrolyte imbalances must be corrected cautiously, particularly sodium, to avoid neurological complications like osmotic demyelination syndrome.

Pseudohyperkalaemia due to haemolysis (rupture of RBCs during sampling) or delayed processing is very common. Taking blood from a limb where an IV infusion is running (e.g., 0.9% saline) will result in a falsely high sodium and low potassium. Forgetting that certain drugs (e.g., spironolactone) can cause insidious potassium rises is a common clinical oversight. Over-reliance on a single creatinine measurement without looking at the trend can lead to missing an evolving AKI.

The U&E panel provides only a snapshot of renal function and does not detect early-stage kidney disease before the GFR significantly drops. Creatinine is a proxy for GFR and is influenced by muscle mass, diet, and age. Urea is affected by high protein intake, GI bleeding, and steroid use, making it an unreliable marker of GFR in isolation. The test does not provide information on the cause of renal failure (e.g., pre-renal vs intrinsic) without further tests like urinalysis or ultrasound.

Understand the NICE criteria for AKI (rise in creatinine >26 micromol/L in 48 hours or 1.5x baseline). Be familiar with the management of hyperkalaemia, specifically the threshold for urgent intervention (usually >6.0 or 6.5 mmol/L or ECG changes). Recognise the significance of a high urea/creatinine ratio in the context of AKI. Know that eGFR is less accurate at values >60 mL/min/1.73m².